Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 7, 1999 - Issue 1
37
Views
54
CrossRef citations to date
0
Altmetric
Original Article

Apoptosis in Vascular Endothelial Cells Caused by Serum Deprivation, Oxidative Stress and Transforming Growth Factor-β

, , , , &
Pages 35-49 | Received 23 Sep 1998, Published online: 13 Jul 2009
 

Abstract

Vascular endothelial cell apoptosis has previously been shown to play a role in the pathogenesis of hypertension-induced vessel deletion and damage. In the present in vitro study we analyse several possible relevant causative factors of vascular endothelial cell apoptosis, namely, serum deprivation and nutrient depletion, oxidative stress in the forms of hypoxia, hyperoxia or free radical damage, and altered levels of transforming growth factor-β1 (TGF-β1) protein. An established cell line, bovine aortic endothelial cells (BAEC), was maintained in complete growth medium (RPMI-1640 plus 15% fetal calf serum and antibiotics, abbreviated as RPMI) in 25cm2 flasks or in 12-well plates on glass coverslips. Confluent but actively-growing cultures were treated with either hypoxia (PO2 of RPMI = 50mmHg), serum-free media (SFM), SFM plus hypoxia, hyperoxia (PO2 of RPMI = 450mmHg), hydrogen peroxide (H2O2, ImM) in SFM, or TGF-β1 protein (10ng/mL) in SFM. Appropriate control cultures were used. BAEC were collected 48h or 72h after all treatments except for TGF-β1 and H2O2 treatments that were collected at 16–18h. Cell death was assessed using morphological characteristics or in situ end labeling (ISEL), cell proliferation assessed using proliferating cell nuclear antigen (PCNA), and TGF-β1 expression assessed using transcript levels or immunohistochemistry. All treatments significantly increased levels of apoptosis over control cultures (P < 0.05), and decreased levels of cell proliferation. Treatment with TGF-β1 protein or SFM plus hypoxia induced greatest levels of apoptosis. TGF-β1 protein and transcript levels were decreased in treated cultures, results suggesting that a paracrine source of TGF-β1 protein would be needed as a cause of endothelial cell apoptosis in vivo. Future therapies against inappropriate vessel deletion in disease states may use the known gene-driven nature of apoptosis to modify this sort of cell death in endothelial cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.